Skip to main content
Clinical Trials/NCT05748015
NCT05748015
Recruiting
Not Applicable

Definition of Autonomic Nervous System Involvement in Patients With Relapsing-remitting and Primary Progressive Multiple Sclerosis

Istituti Clinici Scientifici Maugeri SpA4 sites in 1 country60 target enrollmentMarch 4, 2021

Overview

Phase
Not Applicable
Intervention
quantification of sensory and autonomic small nerve fibers by punch skin biopsy
Conditions
Multiple Sclerosis
Sponsor
Istituti Clinici Scientifici Maugeri SpA
Enrollment
60
Locations
4
Primary Endpoint
Cardiovascular reflex test
Status
Recruiting
Last Updated
15 days ago

Overview

Brief Summary

The goal of this interventional non-pharmacological study is to evaluate the involvement of the autonomic nervous system in patients with relapsing-remitting and primary progressive multiple sclerosis.

The main questions it aims to answer are:

  • Is it possible to define the characteristics of dysautonomia to improve treatment on patients with multiple sclerosis through the management of conditions such as orthostatic hypotension or thermoregulation disorders that inevitably condition the patient's life and the response to rehabilitation ?
  • Does the severity of the functional alterations correlate with impairment of small somatic and autonomic cutaneous nerve fibers in patients with multiple sclerosis ?
  • How much the involvement of the autonomic nervous system affects the clinical history and progression of the disease ?
  • Do different clinical variants of multiple sclerosis manifest with different patterns of involvement of the sensory-autonomic nervous system ?

Participants will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment. Patients will perform a sensory and autonomic functional study and a morphological analysis of cutaneous nerves through skin biopsy.

Researchers will compare results between the two groups (relapsing-remitting and primary progressive) and between patients and data from control subjects.

Registry
clinicaltrials.gov
Start Date
March 4, 2021
End Date
May 30, 2027
Last Updated
15 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • diagnosis of relapsing-remitting and primary progressive multiple sclerosis.

Exclusion Criteria

  • other forms of multiple sclerosis,
  • known other neurological disorders
  • assumption of potentially neurotoxic substances or drugs.

Arms & Interventions

relapsing-remitting multiple sclerosis

Patients with relapsing-remitting multiple sclerosis will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment and will perform a functional and morphological study of sensory and autonomic nervous system, evaluation of peripheral sensory and autonomic nerve fibers performed by skin biopsy.

Intervention: quantification of sensory and autonomic small nerve fibers by punch skin biopsy

relapsing-remitting multiple sclerosis

Patients with relapsing-remitting multiple sclerosis will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment and will perform a functional and morphological study of sensory and autonomic nervous system, evaluation of peripheral sensory and autonomic nerve fibers performed by skin biopsy.

Intervention: Cardiovascular Reflexes testing

relapsing-remitting multiple sclerosis

Patients with relapsing-remitting multiple sclerosis will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment and will perform a functional and morphological study of sensory and autonomic nervous system, evaluation of peripheral sensory and autonomic nerve fibers performed by skin biopsy.

Intervention: Administration of clinical scales evaluating autonomic symptoms, pain small fiber neuropathy symptoms

primary progressive multiple sclerosis

Patients with primary progressive multiple sclerosis will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment and will perform a functional and morphological study of sensory and autonomic nervous system, evaluation of peripheral sensory and autonomic nerve fibers performed by skin biopsy.

Intervention: quantification of sensory and autonomic small nerve fibers by punch skin biopsy

primary progressive multiple sclerosis

Patients with primary progressive multiple sclerosis will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment and will perform a functional and morphological study of sensory and autonomic nervous system, evaluation of peripheral sensory and autonomic nerve fibers performed by skin biopsy.

Intervention: Cardiovascular Reflexes testing

primary progressive multiple sclerosis

Patients with primary progressive multiple sclerosis will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment and will perform a functional and morphological study of sensory and autonomic nervous system, evaluation of peripheral sensory and autonomic nerve fibers performed by skin biopsy.

Intervention: Administration of clinical scales evaluating autonomic symptoms, pain small fiber neuropathy symptoms

Outcomes

Primary Outcomes

Cardiovascular reflex test

Time Frame: At the recruitment

Assessment of Cardiovascular reflex responses to physical challenges.

Sudomotor function test

Time Frame: At the recruitment

Assessment of postganglionic sudomotor function through dynamic sweat test

Secondary Outcomes

  • Quantification of peripheral autonomic nerve fibers(At the recruitment)
  • Quantification of peripheral sensory nerve fibers(At the recruitment)

Study Sites (4)

Loading locations...

Similar Trials